Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
MedComm · 2023-06 · 4 (3)
DOI: 10.1002/mco2.268 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 16.05.2023. Verfasst von Ziying Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Neurology The Second Medical Center & National Clinical Research Center for Geriatric Disease Chinese PLA General Hospital Be…. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The ketogenic diet (KD) is a low‐carbohydrate, high‐fat regime that is protective against neurodegenerative diseases. However, the impact of KD on Parkinson's disease (PD) and its mechanisms remains unclear. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced mouse model of PD was fed with KD for 8 weeks. Motor function and dopaminergic neurons were evaluated. Inflammation in the brain, plasma, and colon tissue were also measured. Fecal samples were assessed by 16S rDNA gene sequencing and untargeted metabolomics. We found that KD protected motor dysfunction, dopaminergic neuron loss, and inflammation in an MPTP mouse model of PD. 16S rDNA sequencing revealed that MPTP administration significantly increased Citrobacter , Desulfovibrio , and Ruminococcus , and decreased Dubosiella , whereas KD treatment reversed the dysbiosis. Meanwhile, KD regulated the MPTP‐induced histamine, N‐acetylputrescine, d ‐aspartic acid, and other metabolites. Fecal microbiota transplantation using feces from the KD‐treated mice attenuated the motor function impairment and dopaminergic neuron loss in antibiotic‐pretreated PD mice. Our current study demonstrates that KD played a neuroprotective role in the MPTP mouse model of PD through the diet–gut microbiota–brain axis, which may involve inflammation in the brain and colon. However, future research is warranted to explore the explicit anti‐inflammatory mechanisms of the gut–brain axis in PD models fed with KD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Neurology The Second Medical Center & National Clinical Research Center for Geriatric Disease Chinese PLA General Hospital Beijing China.
- Department of Geriatric Neurology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China.
- Department of Endocrinology The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China.
- Department of Bio-Medical Diagnostics Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Suzhou Jiangsu China.
- Department of Bio-Medical Diagnostics Jinan Guo Ke Medical Technology Development Co. Ltd. Jinan Shandong China.
- Department of Translational Medical Center Zibo Central Hospital Affiliated to Binzhou Medical University Zibo Shandong China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023). Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites. MedComm, 4(3). https://doi.org/10.1002/mco2.268
Vancouver
Jiang Z, Wang X, Zhang H, Yin J, Zhao P, Yin Q, et al. Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites. MedComm. 2023;4(3). doi:10.1002/mco2.268
BibTeX
@article{Jiang2023,
author = {Jiang, Ziying and Wang, Xinyu and Zhang, Haoqiang and Yin, Jian and Zhao, Peiqing and Yin, Qingqing and Wang, Zhenfu},
title = {Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites},
journal = {MedComm},
year = {2023},
volume = {4},
number = {3},
doi = {10.1002/mco2.268}
}
EUVIMED